| Aβ | Amyloid Beta |
| AD | Alzheimer’s Disease |
| ALS | Amyotrophic Lateral Sclerosis |
| BBB | Blood–Brain Barrier |
| BDNF | Brain-Derived Neurotrophic Factor |
| cAMP | Cyclic Adenosine Monophosphate |
| CBD | Cannabidiol |
| CBG | Cannbigerol |
| CBRs | Cannabinoid Receptors |
| CSF | Cerebrospinal Fluid |
| Cx43 | Connexin 43 |
| ECS | The Endocannabinoid System |
| GVHD | Graft-Versus-Host Disease |
| GFAP | Glial Fibrillary Acidic Protein |
| GPCR | G Protein-Coupled Receptor |
| GTP | Guanosine Triphosphate |
| HD | Huntington’s Disease |
| IL | interleukin |
| iNOS | inducible NOS |
| KO | Knockout |
| MAPK | Mitogen-Activated Protein Kinase |
| MBP | Myelin Basic Protein |
| MD Simulation | Molecular Dynamics Simulation |
| mHTT | Mutant Huntingtin Protein |
| MS | Multiple Sclerosis |
| NADA | N-arachidonoyl dopamine |
| NAGly | N-arachidonyl Glycine |
| NFAT | Nuclear Factor of Activated T cells |
| NMDA | N-Methyl-D-Aspartate Receptors |
| NO | Nitric Oxide |
| NAM | Negative Allosteric Modulation |
| OEA | Lipid Mediator Oleoylethanolamide |
| PD | Parkinson’s Disease |
| PAM | Positive Allosteric Modulation |
| PKA | Protein Kinase A |
| PPARs | Peroxisome Proliferator-Activated Receptors |
| PrPC | Cellular Prion Protein |
| ROS | Reactive Oxygen Species |
| SAH | Subarachnoid Hemorrhage |
| SAM | S-adenosylmethionine |
| SOD-1 | Superoxide Dismutase-1 |
| S1P1 | Sphingosine-1-Phosphate Receptor 1 |
| SRE | Serum Response Element |
| TCN2 | Transcobalamin 2 |
| TDP-43 | Transactive Response DNA-binding Protein 43 |
| Δ9-THC | Δ9-Tetrahydrocannabinol |
| THCV | D9-Tetrahydrocannabivarin |
| Tf | Transferrin |
| TM | Transmembrane Domains |
| TRP | Transient Receptor Potential |
| TRPA1 | Transient Receptor Potential Ankyrin 1 |
| TRPV1 | Transient Receptor Potential Vanilloid 1 |
| VASP | Vasodilator-Stimulated Phosphoprotein |